Association of TRAP1 with infliximab‐induced mucosal healing in Crohn's disease
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Gastroenterology and Hepatology"
DOI: 10.1111/jgh.14696
Abstract: Anti‐tumor necrosis factor (TNF) agents, such as infliximab (IFX), have been increasingly used to induce and maintain disease remission in patients with Crohn's disease (CD). Despite a considerable non‐response rate, little is known about the… read more here.
Keywords: association trap1; trap1 infliximab; disease; induced mucosal ... See more keywords